Source: International Congress 2016 – Long-term outcomes of lung transplantation
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Armin Frille (Leipzig, Germany), Armin Frille, Alexandra Wald, Hans-Juergen Seyfarth, Hubert Wirtz. Malignant tumours in lung transplant recipients. Eur Respir J 2016; 48: Suppl. 60, 2535

Member's Comments

No comment yet.

Related content which might interest you: Evaluation of lung cancer patients with distant organ metastasis Source: International Congress 2014 – Therapy of thoracic tumours: clinical trials and case series Year: 2014 Survival of non small cell lung carcinoma patients with malignant pleural effusions Source: International Congress 2014 – Therapy of thoracic tumours: clinical trials and case series Year: 2014 Osteoporosis in lung transplant patients Source: International Congress 2014 – Novel approaches in the management of lung transplant candidates and recipients Year: 2014 Functional impairment of NK cells in non-small-cell lung cancer Source: International Congress 2014 – Biology and pathology of thoracic tumours Year: 2014 Primary pulmonary sarcomatoid carcinoma: A case series Source: International Congress 2014 – Therapy of thoracic tumours: clinical trials and case series Year: 2014 Incidence, outcomes and risk factors for neoplasms in explanted lungs Source: International Congress 2016 – Long-term outcomes of lung transplantation Year: 2016 Lung transplantation for silicosis, report of 17 patients Source: International Congress 2014 – Maximise lung transplant outcomes: pre- and post-operative issues Year: 2014 Hypogammaglobulinemia in lung transplant candidates Source: International Congress 2016 – Long-term outcomes of lung transplantation Year: 2016 Electrospray-mediated local chemotherapy of lung carcinoma in mice Source: International Congress 2016 – Basic science and case reports in lung cancer Year: 2016 Differentiating incidental lung nodules due to lung cancer from those due to coccidioidomycosis Source: International Congress 2015 – Developments in lung cancer diagnosis Year: 2015 Safety and efficacy of erlotinib in patients with squamous cell lung cancer Source: International Congress 2014 – Therapy of thoracic tumours: clinical trials and case series Year: 2014 Completion pneumonectomy for lung cancer relapse after surgery- What is a real benefit? Source: International Congress 2016 – Special issues in thoracic surgery Year: 2016 Lung cancer in women: Is it different? Source: International Congress 2014 – Epidemiology, pathogenesis and quality management of thoracic tumours Year: 2014 CD33+CD14-CD11b+CD66b+CD15+VEGFR-1hi myeloid derived suppressor cells and their clinical relevance in non-small cell lung cancer Source: International Congress 2014 – Biology and pathology of thoracic tumours Year: 2014 Single institutional experience with primary sarcomas of the lung Source: International Congress 2016 – Basic science and case reports in lung cancer Year: 2016 General characteristics and therapeutic options in lung cancer in Turkey Source: International Congress 2015 – Thoracic oncology around the world: rare cases and local features Year: 2015 A feasibility study of pulmonary rehabilitation at home in patients with lung cancer or malignant pleural mesothelioma treated by (radio-)chemotherapy Source: International Congress 2014 – Best abstracts in pulmonary rehabilitation and exercise training Year: 2014 Surgical treatmment non-small cell lung cancer in the elderly patients Source: International Congress 2015 – Diagnosis and therapy of lung cancer Year: 2015 Indeterminate solitary pulmonary nodule: Surgical diagnosis and models for predicting malignancy Source: International Congress 2014 – Therapy of thoracic tumours: clinical trials and case series Year: 2014 Brain metastatic recurrence following radically treated lung cancer; a retrospective analysis Source: International Congress 2014 – Therapy of thoracic tumours: clinical trials and case series Year: 2014